Transient Elastography with a New Probe for Obese Patients for Non-invasive Staging of Non-alcoholic Steatohepatitis

Overview

Journal Eur Radiol

Specialty Radiology

Date 2010 Jun 8

PMID 20526777

Citations 38

Authors

Mireen Friedrich-Rust

Hassan Hadji-Hosseini

Susanne Kriener

Eva Herrmann

Ishani Sircar

Annika Kau

Stefan Zeuzem

Joerg Bojunga

Affiliations

Soon will be listed here.

Abstract

Objective: Transient elastography (TE) has shown promising results for the staging of liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) with the limitation that 25% of obese patients cannot be examined with the standard TE probe. The aim of this study was to evaluate a new XL probe for obese patients for the staging of liver fibrosis in NAFLD/NASH.

Methods: Fifty patients with NAFLD/NASH and histological assessment of liver fibrosis were included in the study. All patients received TE with the standard probe (M probe) and the new XL probe, and the results were compared with liver histology.

Results: The diagnostic accuracy expressed as the area under the ROC curve for TE measurements with the M probe and the XL probe was 0.80 and 0.82 for the diagnosis of significant fibrosis, and 0.91 and 0.95 for the diagnosis of liver cirrhosis, respectively. Eighty-three percent of the patients who could not be measured with the M probe could be measured using the XL probe.

Conclusion: Transient elastography using the XL probe for obese patients can be performed with comparable diagnostic accuracy to the standard probe and enables the examination of significantly more obese patients.

Citing Articles

Beta-cell, but not autonomic nervous system, function is related to MAFLD in early stages of glucose intolerance.

Dimova R, Chakarova N, Serdarova M, Marinova C, Popov D, Del Prato S BMJ Open Diabetes Res Care. 2024; 12(6.

PMID: 39706674 PMC: 11667428. DOI: 10.1136/bmjdrc-2024-004542.

Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study.

Kalaiyarasi K, Sanchalika A, Hsien Min L, Wei Ming Y, Vishalkumar S, Kuo Chao Y Medicina (Kaunas). 2024; 60(1).

PMID: 38256429 PMC: 10819647. DOI: 10.3390/medicina60010169.

Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary.

Villani R, Lupo P, Sangineto M, Romano A, Serviddio G Diagnostics (Basel). 2023; 13(7).

PMID: 37046454 PMC: 10093430. DOI: 10.3390/diagnostics13071236.

Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Cao Y, Xiang L, Qi F, Zhang Y, Chen Y, Zhou X EClinicalMedicine. 2022; 51:101547.

PMID: 35844772 PMC: 9284399. DOI: 10.1016/j.eclinm.2022.101547.

Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease.

Tamaki N, Kurosaki M, Huang D, Loomba R Hepatol Res. 2022; 52(6):497-507.

PMID: 35352460 PMC: 9718363. DOI: 10.1111/hepr.13764.

References

Machado M, Marques-Vidal P, Cortez-Pinto H . Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006; 45(4):600-6. DOI: 10.1016/j.jhep.2006.06.013. View

Kleiner D, Brunt E, Van Natta M, Behling C, Contos M, Cummings O . Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41(6):1313-21. DOI: 10.1002/hep.20701. View

Maharaj B, Maharaj R, Leary W, Cooppan R, Naran A, Pirie D . Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet. 1986; 1(8480):523-5. DOI: 10.1016/s0140-6736(86)90883-4. View

Cadranel J, Rufat P, Degos F . Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000; 32(3):477-81. DOI: 10.1053/jhep.2000.16602. View

Friedrich-Rust M, Ong M, Martens S, Sarrazin C, Bojunga J, Zeuzem S . Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008; 134(4):960-74. DOI: 10.1053/j.gastro.2008.01.034. View

Adams L, Sanderson S, Lindor K, Angulo P . The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol. 2005; 42(1):132-8. DOI: 10.1016/j.jhep.2004.09.012. View

Castera L, Negre I, Samii K, Buffet C . Pain experienced during percutaneous liver biopsy. Hepatology. 1999; 30(6):1529-30. DOI: 10.1002/hep.510300624. View

Anastasiou J, Alisa A, Virtue S, Portmann B, Murray-Lyon I, Williams R . Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy. Eur J Gastroenterol Hepatol. 2009; 22(4):474-80. DOI: 10.1097/MEG.0b013e328332dd0a. View

Adams L, Lymp J, Sauver J, Sanderson S, Lindor K, Feldstein A . The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005; 129(1):113-21. DOI: 10.1053/j.gastro.2005.04.014. View

10.

Talwalkar J, Kurtz D, Schoenleber S, West C, Montori V . Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007; 5(10):1214-20. DOI: 10.1016/j.cgh.2007.07.020. View

11.

Yoneda M, Yoneda M, Yoneda M, Fujita K, Fujita K, Inamori M . Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut. 2007; 56(9):1330-1. PMC: 1954961. DOI: 10.1136/gut.2007.126417. View

12.

Thein H, Yi Q, Dore G, Krahn M . Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology. 2008; 48(2):418-31. DOI: 10.1002/hep.22375. View

13.

Wong V, Vergniol J, Wong G, Foucher J, Chan H, Le Bail B . Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010; 51(2):454-62. DOI: 10.1002/hep.23312. View

14.

Bravo A, Sheth S, Chopra S . Liver biopsy. N Engl J Med. 2001; 344(7):495-500. DOI: 10.1056/NEJM200102153440706. View

15.

Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y . Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis. 2007; 40(5):371-8. DOI: 10.1016/j.dld.2007.10.019. View

16.

Foucher J, Castera L, Bernard P, Adhoute X, Laharie D, Bertet J . Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol. 2006; 18(4):411-2. DOI: 10.1097/00042737-200604000-00015. View

17.

Regev A, Berho M, Jeffers L, Milikowski C, Molina E, Pyrsopoulos N . Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002; 97(10):2614-8. DOI: 10.1111/j.1572-0241.2002.06038.x. View

18.

Gholam P, Flancbaum L, Machan J, Charney D, Kotler D . Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol. 2007; 102(2):399-408. DOI: 10.1111/j.1572-0241.2006.01041.x. View

19.

Beymer C, Kowdley K, Larson A, Edmonson P, Dellinger E, Flum D . Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg. 2003; 138(11):1240-4. DOI: 10.1001/archsurg.138.11.1240. View

20.

Mehta S, Lau B, Afdhal N, Thomas D . Exceeding the limits of liver histology markers. J Hepatol. 2008; 50(1):36-41. PMC: 2637134. DOI: 10.1016/j.jhep.2008.07.039. View